Who Am I?
Changzhou Highassay Chemical Co., Ltd excels in global sourcing from qualified vendors, ensuring top-quality, traceable, transparent, and sustainable processes. We specialize in supplying hard-to-find materials and deliver them to our customers quickly and efficiently. Our knowledgeable and agile team makes fast, informed decisions to provide the best value and services to our clients. We are dedicated to meeting the research and production needs of pharmaceutical, biotechnology, personal care, agrochemical, and industrial companies, as well as academic and research institutions, hospitals, and government laboratories.

Company Profile
Advantages of R&D and Production in Cooperative Factories
- The Six Key Technological Advantages
- Intelligent Pilot-Scale Production Cluster for Industrial Trials
- Chirality Platform: Specializing in stereoselective synthesis to address the challenges of complex molecular structures.
- Solid Characterization Platform: Predicting drug solubility and stability to gain a competitive edge in patent applications.
- Gene Toxicity and Impurity Control Platform: Achieving detection limits at the ppb level, surpassing EU ICH Q3 standards.
- Metal Residue Control Platform: Employing targeted methods to remove catalyst residues, achieving purity levels exceeding 99.99%.
- Biological Transfer Analysis Platform: Continuously monitoring the migration pathways of APIs throughout the process.
- Multi-dimensional Purification System: Integrating chromatography, crystallization, and distillation technologies to meet the unique purification needs of innovative drugs.
- A matrix of over 30 glass and stainless steel reactors (ranging from 100L to 3,000L).
- An extreme working condition system capable of handling reactions from -100℃ deep cryogenic synthesis to 300℃ high-temperature processes.
- A flexible tonnage-level production line ensuring stable outputs of up to 200kg per batch.
- Fully equipped with high-pressure hydrogenation and precise distillation systems.
- Dual-track quality control systems adhering to both cGMP and ISO standards.
From milligram-level compound screening to tonnage-scale commercial production, the factory has successfully implemented an advanced “R&D-to-mass-production” mindset, enabling seamless laboratory-to-industrial transformation without loss. Annually undertaking more than six major projects, it has become a core manufacturing partner for innovative pharmaceutical enterprises across over 30 countries worldwide. By bridging technological gaps, we ensure that every molecular breakthrough can be confidently industrialized.